Tvardi Therapeutics, Inc. (TVRD)
3.14
-0.01
(-0.32%)
USD |
NASDAQ |
May 01, 16:00
3.13
-0.01
(-0.32%)
After-Hours: 20:00
Tvardi Therapeutics EPS Diluted (Quarterly) : -0.7755 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 8.255 |
| Nektar Therapeutics | -1.778 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.275M |
| Total Expenses (Quarterly) | 7.275M |
| Enterprise Value | -1.153M |
| Earnings Yield | -178.0% |
| Normalized Earnings Yield | -211.59 |